Pacific Shuanglin Bio-pharmacy Co., LTD (SHE:000403)

SHE:000403 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021
Cash & Equivalents	559.09	1,321	1,429	1,001	885.67	102.83
Trading Asset Securities	477.1	282.7	423.34	422.44	234.21	-
Cash & Short-Term Investments	1,036	1,604	1,853	1,423	1,120	102.83
Cash Growth	-39.18%	-13.43%	30.18%	27.09%	989.09%	-7.32%
Accounts Receivable	648.9	668.99	592.77	891.08	581.12	314.17
Other Receivables	6.91	48.2	42.34	49.71	12.83	5.75
Receivables	655.81	717.19	635.11	940.79	593.95	319.93
Inventory	1,601	1,233	909.37	623.69	738.97	441.76
Prepaid Expenses	0.04	0.06	0.3	0.14	0	1.76
Other Current Assets	27.77	24.63	28.6	59.12	16.53	6.44
Total Current Assets	3,321	3,579	3,426	3,047	2,469	872.71
Property, Plant & Equipment	2,051	1,999	1,554	1,297	1,103	410.91
Long-Term Investments	6	6	-	-	-	-
Goodwill	2,615	2,615	2,615	2,615	2,615	-
Other Intangible Assets	191.85	200.33	212.59	192.52	200.05	65.46
Long-Term Deferred Tax Assets	29.34	29.43	49.04	49.09	27.35	11.75
Long-Term Deferred Charges	195.97	153.55	79.47	89.7	67.42	36.04
Other Long-Term Assets	671.48	664.24	694.87	692.81	605.82	282.85
Total Assets	9,081	9,246	8,630	7,982	7,088	1,680
Accounts Payable	137.93	224.26	154.35	158.37	158.7	38.32
Accrued Expenses	259.4	334.84	372.84	373.49	239.21	171.81
Short-Term Debt	396.93	310.49	250.57	275.1	113.52	332.41
Current Portion of Long-Term Debt	37.3	17.06	21.22	8.63	-	-
Current Portion of Leases	3.9	5.06	6.67	7.14	7.05	5.28
Current Income Taxes Payable	17.24	19.07	39.72	43.08	24.22	18.31
Current Unearned Revenue	3.9	6.36	10.76	25.91	11.54	5.2
Other Current Liabilities	47.44	39.84	66.06	67.58	88.04	74.19
Total Current Liabilities	904.04	956.97	922.19	959.31	642.29	645.51
Long-Term Debt	217.89	303.22	196.08	52.89	-	20.02
Long-Term Leases	12.97	18.6	21.48	29.59	20.89	22.33
Long-Term Unearned Revenue	26	26.84	35.6	40.08	49.24	15.95
Long-Term Deferred Tax Liabilities	13.22	14.13	24.26	30.33	36.52	-
Other Long-Term Liabilities	9.65	9	9	9	11.14	9
Total Liabilities	1,184	1,329	1,209	1,121	760.07	712.82
Common Stock	950.4	731.07	733	732.39	732.92	492.43
Additional Paid-In Capital	4,539	-	-	4,779	4,779	52.56
Retained Earnings	2,415	2,435	1,946	1,392	846.23	455.3
Treasury Stock	-	-	-43.17	-36.22	-32	-34.98
Comprehensive Income & Other	0.05	4,758	4,793	0.04	-0	-
Total Common Equity	7,905	7,925	7,429	6,868	6,326	965.32
Minority Interest	-7.02	-7.15	-6.79	-6.4	2.07	1.59
Shareholders' Equity	7,898	7,918	7,422	6,861	6,328	966.91
Total Liabilities & Equity	9,081	9,246	8,630	7,982	7,088	1,680
Total Debt	668.99	654.44	496.02	373.36	141.46	380.04
Net Cash (Debt)	367.2	949.39	1,357	1,050	978.42	-277.21
Net Cash Growth	-68.66%	-30.02%	29.22%	7.30%	-	-
Net Cash Per Share	0.39	1.00	1.43	1.10	1.06	-0.43
Filing Date Shares Outstanding	950.4	950.4	950.06	952.1	952.8	951.65
Total Common Shares Outstanding	950.4	950.4	950.34	952.1	952.8	640.17
Working Capital	2,417	2,622	2,504	2,088	1,827	227.2
Book Value Per Share	8.32	8.34	7.82	7.21	6.64	1.51
Tangible Book Value	5,098	5,110	4,601	4,060	3,511	899.86
Tangible Book Value Per Share	5.36	5.38	4.84	4.26	3.68	1.41
Buildings	1,237	1,180	833.6	701.14	583.25	261.01
Machinery	1,461	1,184	961.1	920.37	729.45	324.38
Construction In Progress	284.16	513.36	582.7	385.73	334.38	32.73

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.